Remove 2014 Remove Competition Remove Doctors Remove Specialization
article thumbnail

Biogen’s $900 million settlement signals scrutiny on speaker fees

Pharmaceutical Technology

Between 2009 and 2014, the time period of Biogen’s alleged misconduct, the standard of care for MS involved the use of Biogen’s immunomodulatory drugs such as Avonex (Interferon beta-1a), Tecfidera (dimethyl fumarate), and Tysabri (natalizumab). More recently, Biogen has been facing competition from dimethyl fumarate generics.

article thumbnail

Medical Sales In Sterile Processing And Infection Prevention With Mark Copeland

Evolve Your Success

He also talks about partnering with small businesses and how they are leading the competition in this particular space. — Watch the episode here Listen to the podcast here Medical Sales In Sterile Processing And Infection Prevention With Mark Copeland We have with us another special guest and he goes by the name of Mark Copeland.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Building CO2-neutral, defossilised supply chains for chemicals

European Pharmaceutical Review

16,17 However, care must be taken to ensure that chemicals from biomass are not produced in competition with food production and do not have a negative impact on the environment or natural habitats. His special interests are in the field of chemical policy and sustainable chemistry. Chem Commun 2014, 50, 9650‒9652.

article thumbnail

Driving Provider Engagement in Value-Based Care

Clarify Health

And frankly, if you’re paying a provider 57% of the 2014 CMS schedule, they’re not going to be terribly excited about you putting this bonus program in front of them when they’re concentrating on that. But at the same time, specialists especially are incredibly special, right? Sorry, that was a loaded question.

article thumbnail

Will A.I. Replace the Medical Sales Workforce and Surgeons? With Edouard Saget

Evolve Your Success

With Edouard Saget In this episode, we have another special guest. What makes Edouard special? Sometimes my competition will take that article and say, “I could plus or minus 10 millimeters.” — Listen to the podcast here Will A.I. Replace the Medical Sales Workforce and Surgeons? He goes by the name of Edouard Saget.

article thumbnail

Liron Fendell

Cadensee

Liron Fendell is the CEO of Nutritional Growth Solutions, or NGS, that specializes in scientific supplement formulas for children of a small stature. Until back in 2014, I met the team at Schneider Children's Medical Center of Israel. They want it to be backed by doctors. Liron Fendell. CEO, nutritional growth solutions.

Retail 52